Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text
.jpg)
.avif)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
.png)
HBS
In Vitro Assays
Cell Culture & Characterization
Toxicology
Ignyte Bio
Blog
What AI Finds in Clinical Notes About Myasthenia Gravis That Claims Data Misses
October 15, 2026
Sponsored by:
Sponsor
Read blog
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Norstella
Blog
In Vivo Study: From Study Design, Execution to Pathology Assessment in One Laboratory at APS
October 8, 2026
Sponsored by:
Sponsor
Read blog
Pharmacology
Disease Models
DMPK
Biomarkers
Toxicology
Applied Pathology Systems
Blog
What to Know About AAV Quality Before the Experiment Begins
September 22, 2026
Sponsored by:
Sponsor
Read blog
DNA & RNA
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
Protein Sciences
Vector Biolabs
Blog
Immortalized vs. Primary Cells: Choosing the Right Model for Your Research
September 15, 2026
Sponsored by:
Sponsor
Read blog
Cell Culture & Characterization
In Vitro Assays
HBS
NHBS
Disease Models
Innoprot
Blog
Connecting Discovery: How Integrated Infrastructure Supports Better Decisions
September 9, 2026
Sponsored by:
Sponsor
Read blog
Antibodies
Protein Sciences
In Vitro Assays
Cell Culture & Characterization
Jubilant Biosys
.png)
Blog
The Evolving Landscape of Drug Discovery for Metabolic Diseases
July 14, 2026
Sponsored by:
Sponsor
Read blog
Pharmacology
In Vitro Assays
Cell Culture & Characterization
BPS Bioscience Inc.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Real-World Data (RWD)
Market Access
No items found.
Blog
Accelerating the Design–Build–Test–Learn Cycle for AI-Driven Antibody Discovery
June 25, 2026
Sponsored by:
Sponsor
Read blog
Antibodies
Protein Sciences
In Vitro Assays
Cell Culture & Characterization
Biointron
Blog
Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery
June 16, 2026
Sponsored by:
Sponsor
Read blog
Discovery Chemistry
Pharmacology
Protein Sciences
SandboxAQ
Blog
Reducing risk in CRO studies: Choosing the right cell models for outsourced research
June 11, 2026
Sponsored by:
Sponsor
Read blog
Cell Culture & Characterization
In Vitro Assays
HBS
Toxicology
Pharmacology
PromoCell
Disease Models
Augusto Montezano
No items found.
American Physiological Society
European Council for Cardiovascular Research
Pharmacology
Cathie G. Miller
David Bunka
Henry Sebesta
BioIVT
Aptamer Group
KromaTiD, Inc.
Scientist.com
HealthEconomics.com
Real-World Data (RWD)
Real-World Evidence (RWE)
Raina Olexa
Mui Van Zandt
IQVIA
HealthEconomics.com
Pharmacology
Cell Culture & Characterization
Toxicology
Edward LeCluyse
Paul Gallant
LifeNet Health LifeSciences
Scientist.com
Disease Models
Ashley Walker
No items found.
American Physiological Society
European Council for Cardiovascular Research
Protein Sciences
Clinical Trials
Chemical & Compound Analysis
Guozheng Shao
Anna Scott
Harvard Bioscience, Inc.
No items found.
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Chitra Lele
Daniel Gutierrez
Pierre Etienne
Clifton Chow
Actu-Real
HealthEconomics.com
Disease Models
Bioimaging
Matthew V. X. Whelan
Jason Otterstrom
Ann-Kathrin Reuschl
IDEA Bio-Medical Ltd.
No items found.
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Andy Stankus
Patricia Medina
Jeffrey Thompson
Ryan Moog
Cerner Enviza
HealthEconomics.com
Disease Models
Christopher West
Transonic Systems Inc.
American Physiological Society
European Council for Cardiovascular Research
DNA & RNA
Cell Culture & Characterization
Bastiaan Bijl
Dylan Mooijman
Single Cell Discoveries
Scientist.com
DNA & RNA
Cell Culture & Characterization
Pharmacology
Marta Walasek
Danielle Nguyen Truong
STEMCELL Technologies Inc.
Scientist.com
Disease Models
Clinical Trials
Cell Culture & Characterization
Carmen Cámara Hijón
Martina Fabris
Bio-Techne
No items found.
Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
.avif)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.
Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM
Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences